Concepedia

Patrizio Mattei

PM

Statistics

Publications

23

Citations

1.5K

H-Index

19

Active since

1996

Affiliations

Roche (Switzerland)(Current)

ETH Zurich

Harvard University

Patrizio Mattei is an author at Roche (Switzerland) specializing in drug discovery, medicinal chemistry, and pharmacology.

ORCID

Publications per year

1996–2024

23

Publications

23

A novel antibiotic class targeting the lipopolysaccharide transporter

Claudia Zampaloni, Patrizio Mattei, Konrad Bleicher et al. · Nature · 2024 · 290 citations · Full text

, , +17

A new antibiotic traps lipopolysaccharide in its intermembrane transporter

Karanbir S. Pahil, Morgan S. A. Gilman, Vadim Baidin et al. · Nature · 2024 · 153 citations · Full text

, , +15

Pharmacological Promiscuity: Dependence on Compound Properties and Target Specificity in a Set of Recent Roche Compounds

Jens‐Uwe Peters, Patrick Schnider, Patrizio Mattei et al. · ChemMedChem · 2009 · 151 citations

, , +11

An orally active chemokine receptor CCR2 antagonist prevents glomerulosclerosis and renal failure in type 2 diabetes

Sufyan G. Sayyed, Mi Heon Ryu, Onkar P. Kulkarni et al. · Kidney International · 2011 · 127 citations · Full text

, , +14

A Real-World Perspective on Molecular Design

Bernd Kuhn, Wolfgang Guba, Jérôme Hert et al. · Journal of Medicinal Chemistry · 2016 · 120 citations · Full text

, , +17

1–5 of 23